Ottawa Heart Institute Research Corporation
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Ottawa Heart Institute Research Corporation sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).
Ottawa Heart Institute Research Corporation: 10 sponsored US clinical trials, 9 recruiting.
Ottawa Heart Institute Research Corporation sponsors 10 registered US clinical trials on ClinicalTrials.gov, 9 of them currently recruiting, and 1 completed. 4 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Shock, Cardiogenic, with 1 trials.
Top-decile sponsor footprint
Ottawa Heart Institute Research Corporation ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
10 total, page 1 of 1
Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out Thrombus in The Emergency Department (LA CLOTTED)
NCT07002450
Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm
NCT06281977
Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock
NCT05298124
CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock
NCT05267886
Cardiac Sarcoidosis Randomized Trial
NCT03593759
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
NCT03630055
Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance
NCT03536312
The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
NCT03447938
Comparing Hypothermic Temperatures During Hemiarch Surgery
NCT02860364
IMAGE-HF Project I-A: Cardiac Imaging in Ischemic Heart Failure (AIMI-HF)
NCT01288560
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 3 |
| Phase 4 | 1 |
Where Ottawa Heart Institute Research Corporation enrollment is open (later-stage tilt)
9 recruiting of 10 indexed (90% open); 1 completed (10%).
Phase mix: 4 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Shock, Cardiogenic (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Ottawa Heart Institute Research Corporation: open-pipeline peers nationwide
Peers matched on 10 registered trials and 90% open enrollment, not the therapeutic-area sidebar.
Ottawa Heart Institute Research Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 10 trials (± recruiting share)
- Adamas Pharmaceuticals · 10 trials · 0% recruiting
- Adverum Biotechnologies · 10 trials · 30% recruiting
- Aevi Genomic Medicine, LLC, a Cerecor company · 10 trials · 0% recruiting
- Agouron Pharmaceuticals · 10 trials · 0% recruiting
Sponsors near 90% open enrollment (± trial volume)
- DualityBio · 90% recruiting · 10 trials
- Efforia · 89% recruiting · 19 trials
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · 93% recruiting · 14 trials
- Johnson & Johnson Enterprise Innovation · 86% recruiting · 7 trials
Related
What to do with this Ottawa Heart Institute Research Corporation page
10 registered trials is a research-attention snapshot, not an endorsement of Ottawa Heart Institute Research Corporation or any single study.
- 9 of Ottawa Heart Institute Research Corporation's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Shock, Cardiogenic is the condition Ottawa Heart Institute Research Corporation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Shock, Cardiogenic trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Ottawa Heart Institute Research Corporation pipeline card: 10 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.